Schizophrenia guidelines across the world: a selective review and comparison. - Wikidata - awgldk - TriplyDB

Schizophrenia guidelines across the world: a selective review and comparison.

Schizophrenia guidelines across the world: a selective review and comparison.

http://www.wikidata.org/entity/Q37949405

about

Unmet needs in the management of schizophrenia Comorbid Obsessive-Compulsive Symptoms in Schizophrenia: Insight into Pathomechanisms Facilitates Treatment Increased mortality in schizophrenia due to cardiovascular disease - a non-systematic review of epidemiology, possible causes, and interventions.Pharmaco-utilisation and related costs of drugs used to treat schizophrenia and bipolar disorder in Italy: the IBIS study.A review of clinical practice guidelines found that they were often based on evidence of uncertain relevance to primary care patients Implementation of a clinical practice guideline for schizophrenia in a specialist mental health center: an observational study The long-term effectiveness of cognitive behavior therapy for psychosis within a routine psychological therapies service Has cognitive behavioural therapy for psychosis been oversold?Pharmacological guidelines for schizophrenia: a systematic review and comparison of recommendations for the first episode.Prevalence and correlates of antipsychotic polypharmacy among outpatients with schizophrenia attending a tertiary psychiatric facility in Nigeria.Quality, bias and service user experience in healthcare: 10 years of mental health guidelines at the UK National Collaborating Centre for Mental Health.Drug treatment developments in schizophrenia and bipolar mania: latest evidence and clinical usefulness.Glutamatergic agents for schizophrenia: current evidence and perspectives.Schizophrenia in 2020: Trends in diagnosis and therapy.Clozapine's critical role in treatment resistant schizophrenia: ensuring both safety and use.Long-Acting Injectable Antipsychotics in Schizophrenia: Literature Review and Practical Perspective, with a Focus on Aripiprazole Once-Monthly.Age at onset and the outcomes of schizophrenia: A systematic review and meta-analysis.Targeted intermittent treatment in chronic schizophrenia Antipsychotic prescribing and its correlates in New Zealand.Developing a Clinician Friendly Tool to Identify Useful Clinical Practice Guidelines: G-TRUST.Ten years of NICE mental health guidelines.Effectiveness of a treatment guideline for schizophrenia in adolescents: Lessons from a middle-income country.

P2860

Q26822917-CE0492FB-4D3E-4B07-B4AD-F18A9B02A7B1 Q27015872-7C8E0600-4004-42AD-8257-B5AD403C4A09 Q34248044-A6888640-815A-4372-9183-4A014176A60E Q34374891-BCBD9C49-EA8D-4799-A62E-722A9EC3A6C5 Q34459480-E737D255-65AB-4D48-BE6E-A8A0B497C093 Q36101841-DE8BC1A4-CCE7-4953-BFE3-31CAE31520AD Q36221314-28E864E4-8BE5-47B7-A920-BF41347A9DFC Q36449406-2879875F-08EE-4D02-8375-36D456B7A40A Q37576827-3EC9C22E-9F77-46D2-A696-A2A60DDC643E Q37582708-224E71F3-635C-47B2-9700-4548A82FF6A3 Q37949399-2D7DED75-EE51-4E7C-AE06-6F19B8556B99 Q38076126-2F94D9E1-1F5E-4F23-8A71-72A63C6B9B31 Q38444551-8C28514C-2649-416A-AC1F-40E4F805DF00 Q38502779-7CA828C3-0D8E-4FB0-A8EB-268375094853 Q38840211-5FF0857B-2C87-4306-8483-7E9A970BADE8 Q38851123-6A454FF6-40CC-4D00-A574-06EE29861505 Q39267126-BA96DFB6-E080-49BF-B276-37EDE68C6306 Q41156644-F06741C7-15F6-4EF2-A891-EEC95C0AE30E Q48875737-04DA4CA1-FB16-440B-A705-4AB652B13660 Q50146983-EF933311-5D31-4BC7-A5B3-C75831C970E2 Q50782112-E46B5227-462B-424D-8C96-5ED04D1690B4 Q51824106-659CDD12-88AA-453E-984A-6120A6533F9F

P2860

Schizophrenia guidelines across the world: a selective review and comparison.

http://www.wikidata.org/entity/Q37949405

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Schizophrenia guidelines across the world: a selective review and comparison.

@en

Schizophrenia guidelines across the world: a selective review and comparison.

@nl

type

label

Schizophrenia guidelines across the world: a selective review and comparison.

@en

Schizophrenia guidelines across the world: a selective review and comparison.

@nl

prefLabel

Schizophrenia guidelines across the world: a selective review and comparison.

@en

Schizophrenia guidelines across the world: a selective review and comparison.

@nl

P1433

Q37949405-CBF618EC-C336-41FF-92CE-F8309704619F

P1476

Q37949405-2BDA9421-9C8D-4F18-AF0A-35FD350753D5

P2093

Q37949405-0E0C328D-6B45-424B-89D2-35346CFB6AD7

Q37949405-3A2335E6-4C72-40AD-B1C3-FB8D867FF233

Q37949405-FDA43ED2-89B7-4A2A-997D-244886DDD876

P2860

Q37949405-00314620-40B5-496C-A2F9-B3A365A40C8E

Q37949405-0727576D-166F-46C8-9889-02BD4C0ACBDA

Q37949405-0A58DE1B-6434-4BBF-BA1F-6D3DAE3CFAE7

Q37949405-0AE4C529-F2D1-494B-A0C6-E6C6A9EBEFAB

Q37949405-1BC9212B-DF49-446E-A278-355A7AE3243F

Q37949405-1EEBD3FE-35EE-492B-A935-577C7F22D90C

Q37949405-4589D548-B67D-407C-A862-C3D7B390C89B

Q37949405-53D6B935-727D-4FFE-9C8E-A3C1BA2363BC

Q37949405-5691F9A2-C390-4738-87A9-493CF52B6587

Q37949405-585DE618-0A06-4925-A1BD-16C5FFF5EA43

P304

Q37949405-03DA3C7B-B8E2-4064-811C-8BBB4EB427E7

P31

Q37949405-FAA43010-22A7-4113-8F6D-50DA94050D3A

P356

Q37949405-3539330E-538C-435B-853C-63F26C9F1AED

P433

Q37949405-BE31CB13-9F66-4E54-90F6-40A83500CAD3

P478

Q37949405-0612A60A-3A49-4F53-AE8D-D655222DA087

P577

Q37949405-67745003-F128-4278-B8A8-8DD35CC6F9D4

P698

Q37949405-393B5FC6-6EB9-4452-80BF-C22D3AF6F0A6

P921

Q37949405-43442616-7206-4A38-AB9A-F00017438FA9

P356

09540261.2011.606801

P1433

International Review of Psychiatry

P1476

Schizophrenia guidelines across the world: a selective review and comparison.

@en

P2093

Mathias Riesbeck

http://www.w3.org/2001/XMLSchema#string

Thomas Wobrock

http://www.w3.org/2001/XMLSchema#string

Wolfgang Gaebel

http://www.w3.org/2001/XMLSchema#string

P2860

A systematic review of longitudinal outcome studies of first-episode psychosis

Improving the quality of health care: using international collaboration to inform guideline programmes by founding the Guidelines International Network (G-I-N)

Development and validation of an international appraisal instrument for assessing the quality of clinical practice guidelines: the AGREE project

Effectiveness of antipsychotic drugs in patients with chronic schizophrenia

Second-generation versus first-generation antipsychotic drugs for schizophrenia: a meta-analysis

Effectiveness and efficiency of guideline dissemination and implementation strategies

The Schizophrenia Patient Outcomes Research Team (PORT): updated treatment recommendations 2009.

Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the treatment of schizophrenia and related disorders.

AGREE II: advancing guideline development, reporting and evaluation in health care.

Randomized controlled trial of the effect on Quality of Life of second- vs first-generation antipsychotic drugs in schizophrenia: Cost Utility of the Latest Antipsychotic Drugs in Schizophrenia Study (CUtLASS 1).

P304

379-387

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/09540261.2011.606801

http://www.w3.org/2001/XMLSchema#string

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22026495

http://www.w3.org/2001/XMLSchema#string

P921